PA
STRO icon

Perceptive Advisors’s Sutro Biopharma STRO Stock Holding History

Perceptive Advisors’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.8M Buy
+715,307
New +$12.9M 0.35% 56

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors's STRO Position: Q1 2026 in Review

Perceptive Advisors opened a new position in Sutro Biopharma (STRO) in Q1 2026: 715,307 shares worth $17.8M. The stake represents 0.35% of the portfolio and ranks #56 among its holdings.

78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Perceptive Advisors held 715,307 shares of Sutro Biopharma worth $17.8M as of Q1 2026.
  • Sutro Biopharma was a new Perceptive Advisors position in Q1 2026.
  • Sutro Biopharma made up 0.35% of Perceptive Advisors's portfolio in Q1 2026, its #56 holding.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.